Summary
Machine-generated summaryA Romanian contracting authority is procuring various medicines under the national Oncology Programme, divided into 76 lots. Products include oncology medicines such as ipilimumab, liposomal doxorubicin, bleomycin, carboplatin, oxaliplatin, vincristine, ramucirumab, trastuzumab deruxtecan, pembrolizumab, etoposide, docetaxel and zoledronic acid, with maximum quantities specified per product. The contracting authority will respond to clarification requests submitted at least 11 days before the offer submission deadline. Proposals to amend contractual clauses that are clearly disadvantageous to the contracting authority will not be accepted. No estimated value or specific deadline date is stated in the notice.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profileRecent awards
Similar tenders
1
day left
€345,510
est. value
1
day left
€1,009,235
est. value
1
day left
€1,053,675
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €9,890,377
- Buyer track record on Aperlena
- 17 notices tracked · 11 awarded
- €6,838,004 in awarded contracts
Never miss a tender like this
295 new notices in Medical equipment & pharmaceuticals in Romania in the last 7 days. Get an email when new ones appear. Free.
Set up my alert